Lexaria Bioscience News

Lexaria Bioscience Explores Oral Liraglutide Potential

TipRanksDec 9 11:02 ET

Lexaria Bioscience Engages CRO for Human Pilot Study of DehydraTEHC-liraglutide

TipRanksDec 9 09:43 ET

Liraglutide Processed With DehydraTECH to Be Studied in Human GLP-1 Study #5

AccesswireDec 9 09:10 ET

Insider Purchase: Chief Executive Officer of $LEXX (LEXX) Buys 22,828 Shares

Quiver QuantitativeDec 3 14:15 ET

Lexaria Bioscience's DehydraTECH Shows Promising Potential With Positive Study Outcomes and Strong Financial Position

TipRanksDec 2 06:25 ET

BTV Features These Stocks to Watch: Contango Ore, First Nordic Metals, Champion Iron, Prime Mining, Lexaria Bioscience, Osisko Development, West Red Lake Gold Mines, & Surge Battery Metals

newsfileNov 30 11:00 ET

Express News | Lexaria Bioscience Files Prospectus for Resale From Time to Time by Selling Stockholder of up to 4.6 Mln Shares of Common Stock - SEC Filing

ReutersNov 26 16:46 ET

10-K: FY2024 Annual Report

SECNov 26 13:03 ET · Announcements

Lexaria Bioscience Provides Strategic Update; Says Semaglutide Being Investigated For Applications In Heart Disease, Alzheimer's, Liver Disease, And More; GLP-1 Drugs Expected To Generate Multi-Hundreds Of Billions Of Revenues In The Years To Come

BenzingaNov 26 09:25 ET

Lexaria Bioscience Completes Dosing for GLP-1 Human Pilot Study #3

TipRanksNov 25 09:15 ET

Express News | Lexaria Completes Dosing In Human Pilot Study #3 Investigating DehydraTECH-Processed Tirzepatide From Zepbound

BenzingaNov 25 09:07 ET

H.C. Wainwright Maintains Lexaria Bioscience(LEXX.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 25 07:31 ET · Ratings

HC Wainwright & Co. Reiterates Buy on Lexaria Bioscience, Maintains $10 Price Target

BenzingaNov 25 07:02 ET · Ratings

Lexaria Bioscience Analyst Ratings

BenzingaNov 25 07:00 ET · Ratings

Earnings Week Ahead: CRWD, DELL, ZM, WDAY, HPQ, M, BBY and More

Seeking AlphaNov 24 08:01 ET

Express News | Lexaria : Study Work Has Already Begun With Completion and Final Reporting Expected in May, 2025

ReutersNov 14 09:14 ET

Express News | Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study; Terms Not Disclosed

BenzingaNov 14 09:12 ET

Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss

AccesswireNov 13 09:20 ET

Positive Partial 12-Week Blood Sugar Results From Lexaria's GLP-1 Diabetes Animal Study

AccesswireOct 24 09:10 ET

Express News | Lexaria Bioscience Corp: Positive Partial 12-Week Body Weight Results From Lexaria’s GLP-1 Diabetes Animal Study

ReutersOct 22 09:22 ET